Comparison of the current international guidelines on the management of HCC

Area of Science:

• Hepatology
• Oncology
• Clinical Practice Guidelines

Background:

• Management of hepatocellular carcinoma (HCC) is increasingly complex.
• Major hepatology societies develop evidence-based guidelines for HCC treatment.
• Recent updates from American, Asian Pacific, and European societies necessitate comparative analysis.

Purpose of the Study:

• To compare the latest HCC management guidelines from three major international societies.
• To identify commonalities and discrepancies in recommendations.
• To pinpoint areas requiring further research for future guideline revisions.

Main Methods:

• Comparative analysis of published guidelines from the American, Asian Pacific, and European hepatology societies.
• Systematic review of key recommendations and differences.
• Identification of emerging research trends impacting HCC management.

Main Results:

• Significant overlap exists in core recommendations across the compared HCC guidelines.
• Notable differences are observed in specific treatment modalities and staging considerations.
• Several areas of active research are identified, suggesting imminent needs for guideline updates.

Conclusions:

• Clinicians benefit from understanding the nuances between major HCC guidelines.
• Ongoing research is crucial for refining HCC management strategies and future guideline development.
• Harmonization of guidelines may be facilitated by addressing identified research gaps.